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ABSTRACT 
The criteria for the classification of systemic lupus erythematosus were 
proposed in 1971 by the American College of Rheumatology. They have 
been clarified since then, but need to be revised. 
Objective. To determine the diagnostic value of the criteria for the 
classification of systemic lupus erythematosus proposed by the American 
College of Rheumatology. 
Materials and methods. 370 patients (331 women (89.46%) and 39 men 
(10.54%), average age 41.24 ± 0.63 years) with SLE and 234 patients (150 
women (64.10%) and 84 men (35.90%), average age 48.82 ± 0.85 years) 
with other rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, 
ankylosing spondylitis) were randomly enrolled into the study. The 
patients had undergone comprehensive clinical-laboratory and 
instrumental examinations in 2010–2018 before they received treatment. 
The analysis was conducted in MS Excel and SPSS by constructing 
contingency tables and calculating indicators of diagnostic value. 
Results. We identified the following criteria as those that can with statistical 
significance predict the presence of systemic lupus erythematosus: butterfly 
rash, photosensitivity, serositis (pleuritis, pericarditis), neurologic disorders 
(seizures, psychosis), thrombocytopenia, renal disorders (proteinuria, 
cylindruria), anti-dsDNA and antinuclear antibodies. 
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Topicality. The criteria for the classification of systemic lupus erythematosus (SLE) were first 
proposed in 1971 by the American College of Rheumatology (ACR) [2, 3]. Although they have been 
revised several times since then (1982 [5], 1997 [4]), according to literature and our own clinical 
experience, there are often situations where the diagnosis of the disease is obvious, but the number of 
met criteria is not sufficient and vice versa. Such situations have prompted this study.  
Objective. To determine the diagnostic value of systemic lupus erythematosus classification 
criteria proposed by the American College of Rheumatology (1997). 
Materials and methods. Having obtained written consents to participate in comprehensive 
examinations in accordance with the principles of Helsinki Human Rights Declaration, Council of 
Europe Convention on Human Rights and Biomedicine, the relevant laws of Ukraine and other 
international instruments, after stratification by the presence of SLE and other rheumatic diseases 
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(rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis), we randomly enrolled 370 patients 
with SLE (hereinafter referred to as „SLE group”; 331 women (89.46%) and 39 men (10.54%), aged 
18 to 74 years) and 234 patients with other rheumatic diseases (hereinafter referred to as „comparison 
group” (CG), 150 women (64.10%) and 84 men (35.90%), aged 19 to 84 years) into the study. All 
patients had undergone comprehensive clinical-laboratory and instrumental examinations of all organs 
and systems before they received treatment in 2010-2018 at the Rheumatology Department of Lviv 
Regional Clinical Hospital, the clinical base of the Departments of Internal Medicine No. 1 and No. 2 
of Danylo Halytsky National Medical University. The treatment was administered in accordance with 
the Order of the Ministry for Health of Ukraine No. 676 of October 12, 2006 “On the Approval of 
Protocols for the Provision of Medical Care under the Rheumatology Specialty”. In addition to routine 
examinations, all patients underwent tests for anti-double stranded DNA (anti-dsDNA) antibodies, 
antiphospholipid antibodies (IgG and IgM), lupus anticoagulants, antinuclear antibodies (ANAs).  
The study was based on the statistical analysis with the calculation of the odds of establishing 
a correct diagnosis of SLE. It was conducted in two consecutive steps. The first step involved 
assessing the diagnostic value of the ACR criteria, and the second step involved assessing the 
diagnostic value of their individual components. 
The reliable probability of diagnosis was determined using indicators of diagnostic value: 
sensitivity, specificity, and accuracy. Sensitivity (true positive rate) is an indicator of medical statistics 
that denotes the proportion of positive results correctly identifying the disease. Specificity (true 
negative rate) is an indicator that denotes the proportion of negative results correctly identifying 
healthy people (as not having that disease). Accuracy is a share of correct assessments (diagnoses) 
made on the basis of information about positive or negative results [1]. The odds ratio and the 
coefficient of association (contingency) were also determined using these indicators. The odds ratio is 
a statistic that shows how the absence or presence of a particular result was associated with the 
presence or absence of a particular disease in a group. The coefficient of association (contingency) is a 
statistic that denotes the strength of the stochastic relationship between qualitative manifestations – 
alternative random variables [1]. 
The actual data was processed on a personal computer with MS Excel and SPSS by constructing 
contingency tables and calculating indicators of diagnostic value. The relationship between SLE and the 
indicator in question was considered to be statistically significant if the absolute number of association 
coefficient exceeded 0.5 (or if the absolute number of contingency coefficient exceeded 0.3). 
Results and discussion. The results of the first step are shown in Table 1 and Figure 1. The 
purpose of the first step was to determine the diagnostic value of the ACR criteria by conducting 
statistical analysis and calculating the odds of making the correct diagnosis (SLE).  
Table 1. Diagnostic Value of Systemic Lupus Erythematosus Classification Criteria as 
Proposed by the American College of Rheumatology in 1997  
No. Diagnostic criteria Sensitivity,% Specificity,% Accuracy,% Odds ratio 
Coefficient 
of 
association 
Coefficient 
of 
contingency 
1. Malar rash 54.32 100.00 72.02 - 1 0.56 * 
2. Discoid rash 9.73 100.00 44.70 - 1 0.20 
3. Photosensitivity 34.32 100.00 59.77 - 1 0.41 * 
4. Oral ulcers 18.85 100.00 05.05 - 1 0 
5. Arthritis 20.54 7.27 15.40 0.02 -0.96 - 
6. Serositis 22.70 100.00 52.65 - 1 0.32 * 
7. Renal disorders 48.38 86.48 62.67 6.00 0.71 * - 
8. 
Neurologic 
disorders 
12.43 98.70 45.59 10.79 0.83 * - 
9. 
Hematologic 
disorders 
45.68 52.56 48.34 0.93 -0.04 - 
10. 
Immunologic 
disorders 
88.30 96.55 89.98 211.4 0.99 * - 
11. ANAs 87.99 84.21 87.35 39.06 0.95 * - 
Note: * − the presence of SLE is statistically significant, p <0.05. 
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Fig.1. Prevalence of the ACR Criteria in Patients with SLE and in Patients with Other Rheumatic Diseases 
The malar rash (butterfly rash) was detected in 201 patients (54.32%) of the SLE group. No 
patients (0.00%) of the comparison group had an erythematous rash on their faces. The sensitivity of 
the criterion was 54.32%, specificity – 100.00%, accuracy – 72.02%. There was a statistically 
significant positive relationship between the criterion and the presence of SLE in patients (contingency 
coefficient of 0.56) – confirming the diagnostic value of the criterion. 
The discoid rash was detected in only 36 patients (9.73%) of the SLE group. It was not 
detected in any patient (0.00%) of the comparison group. The sensitivity of the criterion was 9.73%, 
specificity – 100.00%, and accuracy – 44.70%. There was no statistically significant relationship 
between the criterion and the presence of the disease (contingency coefficient of 0.20). 
Photosensitivity – rash due to atypical reaction to sunlight – occurred in 127 patients (34.32%) of 
the SLE group. It did not occur in any patient (0.00%) of the comparison group. The sensitivity of the 
criterion was 34.32%, specificity – 100.00%, and accuracy – 56.77%. There was no statistically significant 
relationship between the presence of photosensitivity and SLE (contingency coefficient of 0.41). 
Oral ulcers were detected, due to objective examinations, in 69 patients (18.85%) of the SLE 
group. There were no such lesions in patients (0.00%) of the comparison group. The sensitivity of the 
criterion was 18.85%, specificity was 100.00%, and accuracy was 50.50%. There was no significant 
relationship between the criterion and the presence of SLE (contingency coefficient of 0.29). 
Arthritis was detected in 76 patients (20.54%) of the SLE group and in 217 patients (92.74%) 
of the comparison group. The sensitivity of the criterion for the diagnosis of SLE was 20.54%, 
specificity was 7.27%, and accuracy was 15.40%. There was a statistically significant negative 
relationship between the presence of arthritis and SLE (association coefficient of -0.96). Consequently, 
the presence of arthritis significantly rules out SLE. 
Serositis, including the presence of pericarditis and/or pleuritis, was detected in 84 patients 
(22.70%) of the SLE group. It was not detected in any patient (0.00%) of the comparison group. The 
sensitivity of the criterion was 22.70%, specificity – 100.00%, accuracy – 52.65%. There was a statistically 
significant relationship between the presence of serositis and SLE (contingency coefficient of -0.32). 
Renal disorders – proteinuria or cylindruria – were detected in 179 patients (48.38%) of the 
SLE group and in 30 patients (13.51%) of the comparison group. The sensitivity of the criterion was 
48.38%, specificity – 86.49%, and accuracy – 62.67%. There was a statistically significant positive 
relationship between the presence of the criterion and SLE (association coefficient of 0.71). We 
found that renal disorders were 6.00 times more prevalent in patients with SLE than in patients with 
other rheumatic diseases. 
Neurologic disorders, including seizures and/or mental disorders, were detected in 46 patients 
(12.43%) of the SLE group. Only three patients (1.30%) of the comparison group had neurologic 
disorders. The sensitivity of the criterion was 12.43%, specificity – 98.70%, accuracy – 45.60%. There 
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was a statistically significant positive relationship between the presence of the criterion and SLE 
(association coefficient of 0.83). We found that neurologic disorders were 10.79 times more prevalent 
in patients with SLE than in patients with other rheumatic diseases. 
Hematologic disorders include hemolytic anemia with reticulocytosis, thrombocytopenia, 
lymphopenia, and/or leukopenia. According to the results of laboratory examinations, we detected 
hematological disorders in 169 patients (45.68%) of the SLE group and in 111 patients (47.44%) of the 
comparison group. According to our calculations, the presence of any hematological disorder does not 
indicate SLE – there was no statistically significant relationship between the presence of the criterion 
and SLE (sensitivity was 45.68%, specificity – 52.56%, accuracy – 48.34%, association coefficient of 
-0.04). According to the results of statistical analysis, hematological disorders are less prevalent in 
patients with SLE than in patients with other rheumatic diseases. 
Immunologic disorders (anti-dsDNA antibodies, antiphospholipid antibodies (IgM and IgG), lupus 
anticoagulants) were detected in 302 patients (88.30%) of the SLE group. Immunologic disorders were also 
detected in three patients (3.45%) of the comparison group. The sensitivity of the criterion was 88.30%, 
specificity – 96.55%, accuracy – 89.98%. There was a statistically significant positive relationship between 
the criterion and SLE (association coefficient of 0.99). Immunologic disorders were 211.40 times more 
prevalent in patients with SLE than in patients with other rheumatic diseases. 
ANAs were detected in 249 patients (87.99%) of the SLE group and in nine patients (15.79%) 
of the comparison group. The sensitivity of ANAs as the criterion for SLE was 87.99%, specificity 
was 84.21%, and accuracy was 87.35%. There was a statistically significant positive relationship 
between the presence of the criterion and SLE (association coefficient of 0.95). According to the 
results of statistical analysis, ANAs were 39.06 times more prevalent in patients with SLE than in 
patients with other rheumatic diseases. 
The analysis of the diagnostic value of the ACR criteria in the case of the SLE group suggests 
that SLE may be predicted only by some of the currently approved criteria – namely, butterfly rash, 
photosensitivity, serositis, renal disorders, neurologic disorders, immunologic disorders, and ANAs. 
Other criteria, such as discoid rash, oral ulcers, hematological disorders, do not help to predict the 
presence of SLE, and arthritis – on the contrary – rules out the disease. 
The results of the second step of the study are shown in Table 2 and in Figure 2. The purpose 
of the second step was to determine the diagnostic value of the individual components of certain ACR 
criteria – namely, the presence of pericarditis, pleuritis, proteinuria, cylindruria, hemolytic anemia with 
reticulocytosis, thrombocytopenia, lymphopenia, leukopenia, anti-dsDNA antibodies, antiphospholipid 
antibodies (IgM and IgG), and lupus anticoagulants. 
Table 2. Diagnostic Value of the Components of Certain ACR Criteria for the Classification of 
Systemic Lupus Erythematosus  
No. Diagnostic criteria Sensitivity, % Specificity, % Accuracy, % 
Odds 
ratio 
Coefficient 
of 
association 
Coefficient 
of 
contingency 
1. 
Serositis 
Pericarditis 17.30 100.00 49.34 - 1 0.27 
2. Pleuritis 13.51 100.00 47.02 - 1 0.24 
3. Renal 
disorders 
Proteinuria 46.49 85.13 60.98 4.98 0.67 * - 
4. Cylindruria 11.35 98.63 43.80 9.22 0.80 * - 
5. Neurologic 
disorders 
Seizures 0.81 98.72 38.74 0.63 -0.23 - 
6. Psychosis 6.49 100.00 42.71 - 1 0.16 
7. 
Hematologic 
disorders 
Hemolytic anemia 
with reticulocytosis 
02.16 83.33 33.61 0.11 -0.80 - 
8. Thrombocytopenia 13.24 97.44 45.86 5.80 0.71 * - 
9. Lymphopenia 07.57 69.23 31.46 0.18 -0.69 - 
10. Leukopenia 37.30 83.33 55.13 2.97 0.49 - 
11. 
Immunologic 
disorders 
Anti-dsDNA 90.19 96.29 91.47 239.20 0.99 * - 
12. 
Antiphospholipid 
IgM 
26.95 100.00 28.47 - 1 0.09 
13. 
Antiphospholipid 
IgG 
24.00 100.00 25.49 - 1 0.08 
14. Lupus anticoagulant 3.39 - 03.39 - - - 
Note: * − the presence of SLE is statistically significant, p <0.05. 
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Fig.2. Prevalence of the components of certain ACR criteria in patients with SLE and in patients with 
other rheumatic diseases 
Pericarditis was detected in 64 patients (17.30%) of the SLE group, and pleuritis was detected 
in 50 patients (13.51%) of the SLE group. Neither pericarditis nor pleuritis was detected in patients 
(0.00%) of the comparison group. The sensitivity of the pericarditis component was 17.30%, 
specificity – 100.00%, accuracy – 49.34%. There was no statistically significant relationship between 
the presence of pericarditis and SLE (contingency coefficient of 0.27). The sensitivity of the pleuritis 
component was 13.51%, specificity – 100.00%, accuracy – 47.02%. There was no statistically 
significant relationship between the presence of pleuritis and SLE (contingency coefficient of 0.24). 
Proteinuria was detected in 172 patients (46.49%) of the SLE group and in 33 patients 
(14.86%) of the comparison group. Cylindruria occurred in 42 patients (11.35%) of the SLE group and 
in three patients (1.37%) of the comparison group. The sensitivity of the proteinuria component was 
46.49%, specificity – 85.14%, accuracy – 60.98%. There was a statistically significant positive 
relationship between the presence of proteinuria and the diagnosis of SLE (association coefficient of 
0.67). The sensitivity of the cylindruria component was 11.35%, specificity – 98.63%, accuracy – 
43.80%. There was also a statistically significant positive relationship between the presence of 
cylindruria and the diagnosis of SLE (association coefficient of 0.80). 
Seizures and psychosis were found in the medical records of three patients (0.81%) and 24 
patients (6.49%) of the SLE group, respectively. Three patients (1.28%) of the comparison group had 
seizures, and nobody (0.00%) had psychosis. There were no statistically significant relationships 
between the presence of seizures and SLE (sensitivity 0.81%, specificity 98.72%, accuracy 38.74%, 
association coefficient of -0.23), as well as between the presence of psychosis and SLE (sensitivity 
6.49%, specificity 100.00%, accuracy 42.72%, contingency coefficient of 0.16). 
According to the results of examinations, we detected following hematologic disorders in the 
patients of the SLE group: hemolytic anemia – in eight patients (2.16%), thrombocytopenia - in 49 
patients (13.24%), lymphopenia – in 28 patients (7.57%) and leukopenia – in 138 patients (37.30%). 
39 patients (16.67%) of the comparison group had anemia, six patients (2.56%) of the comparison 
group had thrombocytopenia, 72 patients (30.77%) of the comparison group had lymphopenia, and 39 
patients (16.67%) of the comparison group had leukopenia. There was a statistically significant 
positive relationship between the presence of thrombocytopenia and SLE (sensitivity 13.24%, 
specificity 97.44%, accuracy 45.86%, association coefficient of 0.71). The relationship between the 
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presence of anemia and SLE was statistically significant and negative (sensitivity 2.16%, specificity 
83.33%, accuracy 33.61%, association coefficient of -0.80), i.e. the prevalence of anemia was 
significantly lower in patients with SLE than in patients with other rheumatic diseases. Lymphopenia 
was also significantly more prevalent in patients with other rheumatic diseases than in patients with 
SLE (sensitivity 7.57%, specificity 69.23%, accuracy 31.46%, association coefficient of -0.69). There 
was no statistically significant relationship between the presence of leukopenia and SLE (sensitivity 
37.30%, specificity 83.33%, accuracy 55.13%, association coefficient of 0.49). 
Anti-dsDNA antibodies were detected in 276 patients (90.20%) of the SLE group. 
Antiphospholipid antibodies IgM were detected in 38 patients (26.95%), and antiphospholipid 
antibodies IgG were detected in 36 patients (24.00%) of the SLE group. Two patients (3.39%) of the 
SLE group had lupus anticoagulants. Only three patients (3.70%) of the comparison group had anti-
dsDNA antibodies. No other immunologic disorders were detected in patients of the comparison group. 
We found a statistically significant positive relationship between the presence of anti-dsDNA 
antibodies and SLE (sensitivity 90.20%, specificity 96.30%, accuracy 91.47%, association coefficient 
of 0.99). There were no statistically significant relationships between the presence of other 
immunologic disorders and SLE: between the presence of antiphospholipid antibodies IgM and SLE 
(sensitivity 29.95%, specificity 100.00%, accuracy 28.47%, contingency coefficient of 0.08), 
antiphospholipid antibodies IgG and SLE (sensitivity 24.00%, specificity 100.00%, accuracy 25.49%, 
contingency coefficient of 0.07), lupus anticoagulants and SLE (sensitivity 3.40%). 
Therefore, we identified proteinuria, cylindruria, thrombocytopenia, and the presence of anti-
dsDNA antibodies as independent statistically significant criteria for the diagnosis of SLE, with high 
sensitivity, specificity, and accuracy. Other criteria (disorders), such as hemolytic anemia and 
lymphopenia, in contrast, are more prevalent in patients with other rheumatic diseases than in patients 
with SLE and are more likely to predict the absence of the latter. Pericarditis, pleuritis, seizures, 
psychosis, leukopenia, the presence of antiphospholipid antibodies IgM and IgG, and lupus 
anticoagulants have no statistically significant relationship with the disease.  
Conclusions. We determined the diagnostic value of the criteria for the classification of 
systemic lupus erythematosus proposed by the American College of Rheumatology and found that 
butterfly rash, photosensitivity, serositis (pleuritis or pericarditis), neurologic disorders (seizures or 
psychosis), thrombocytopenia, renal disorders (proteinuria or cylindruria), anti-dsDNA and antinuclear 
antibodies had statistically significant sensitivity, specificity, and accuracy. In contrast, other ACR 
criteria were more characteristic of a number of other rheumatic diseases. 
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